A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as ...
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...
Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...
A new study of more than 2,900 patients provides evidence that it’s likely best to use as little corticosteroid medicine as ...
Recurrent pericarditis occurs in one fifth of patients with systemic lupus erythematosus, with higher rates being observed in ...
In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.
Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).
Singer Muni Long details living with lupus and how she struggles with symptoms in an exclusive interview with PEOPLE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback